Health Canada Drops Suffix in Biologic and Biosimilar Naming Convention

Published date21 February 2019
Law FirmGoodwin
Subject MatterFDA,Biosimilars,Biologics,Canada,Pharmaceutical Industry,Health Canada

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT